FOXA2 and renal cell carcinoma: In this study, we identified FOXA2 as a key driver oncogene that activates HIF2α expression by directly binding to the EPAS1 (or HIF2A, encoding HIF2α) promoter, promoting RCC cell proliferation in vitro and in vivo.